Cargando…

(−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma

Liver cancers, such as hepatocellular carcinoma (HCC), are a highly prevalent cause of cancer-related deaths. Current treatments to combat liver cancer are limited. (−)-Agelasidine A, a compound isolated from the methanol extract of Agelas nakamurai, a sesquiterpene guanidine derived from sea sponge...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, I-Ta, Lin, Shih-Chao, Chu, Yi-Chia, Wen, Ya, Lin, You-Cheng, Cheng, Wen-Chien, Sheu, Jyh-Horng, Lin, Chi-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875608/
https://www.ncbi.nlm.nih.gov/pubmed/35200638
http://dx.doi.org/10.3390/md20020109
_version_ 1784657973456404480
author Lu, I-Ta
Lin, Shih-Chao
Chu, Yi-Chia
Wen, Ya
Lin, You-Cheng
Cheng, Wen-Chien
Sheu, Jyh-Horng
Lin, Chi-Chien
author_facet Lu, I-Ta
Lin, Shih-Chao
Chu, Yi-Chia
Wen, Ya
Lin, You-Cheng
Cheng, Wen-Chien
Sheu, Jyh-Horng
Lin, Chi-Chien
author_sort Lu, I-Ta
collection PubMed
description Liver cancers, such as hepatocellular carcinoma (HCC), are a highly prevalent cause of cancer-related deaths. Current treatments to combat liver cancer are limited. (−)-Agelasidine A, a compound isolated from the methanol extract of Agelas nakamurai, a sesquiterpene guanidine derived from sea sponge, has antibacterial activity. We demonstrated its anticancer capabilities by researching the associated mechanism of (−)-agelasidine A in human liver cancer cells. We found that (−)-agelasidine A significantly reduced viability in Hep3B and HepG2 cells, and we determined that apoptosis was involved in the (−)-agelasidine A-induced Hep3B cell deaths. (−)-Agelasidine A activated caspases 9, 8, and 3, as well as PARP. This effect was reversed by caspase inhibitors, suggesting caspase-mediated apoptosis in the (−)-agelasidine A-treated Hep3B cells. Moreover, the reduced mitochondrial membrane potential (MMP) and the release of cytochrome c indicated that the (−)-agelasidine A-mediated mitochondrial apoptosis was mechanistic. (−)-Agelasidine A also increased apoptosis-associated proteins (DR4, DR5, FAS), which are related to extrinsic pathways. These events were accompanied by an increase in Bim and Bax, proteins that promote apoptosis, and a decrease in the antiapoptotic protein, Bcl-2. Furthermore, our results presented that (−)-agelasidine A treatment bridged the intrinsic and extrinsic apoptotic pathways. Western blot analysis of Hep3B cells treated with (−)-agelasidine A showed that endoplasmic reticulum (ER) stress-related proteins (GRP78, phosphorylated PERK, phosphorylated eIF2α, ATF4, truncated ATF6, and CHOP) were upregulated. Moreover, 4-PBA, an ER stress inhibitor, could also abrogate (−)-agelasidine A-induced cell viability reduction, annexin V+ apoptosis, death receptor (DR4, DR5, FAS) expression, mitochondrial dysfunction, and cytochrome c release. In conclusion, by activating ER stress, (−)-agelasidine A induced the extrinsic and intrinsic apoptotic pathways of human HCC.
format Online
Article
Text
id pubmed-8875608
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88756082022-02-26 (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma Lu, I-Ta Lin, Shih-Chao Chu, Yi-Chia Wen, Ya Lin, You-Cheng Cheng, Wen-Chien Sheu, Jyh-Horng Lin, Chi-Chien Mar Drugs Article Liver cancers, such as hepatocellular carcinoma (HCC), are a highly prevalent cause of cancer-related deaths. Current treatments to combat liver cancer are limited. (−)-Agelasidine A, a compound isolated from the methanol extract of Agelas nakamurai, a sesquiterpene guanidine derived from sea sponge, has antibacterial activity. We demonstrated its anticancer capabilities by researching the associated mechanism of (−)-agelasidine A in human liver cancer cells. We found that (−)-agelasidine A significantly reduced viability in Hep3B and HepG2 cells, and we determined that apoptosis was involved in the (−)-agelasidine A-induced Hep3B cell deaths. (−)-Agelasidine A activated caspases 9, 8, and 3, as well as PARP. This effect was reversed by caspase inhibitors, suggesting caspase-mediated apoptosis in the (−)-agelasidine A-treated Hep3B cells. Moreover, the reduced mitochondrial membrane potential (MMP) and the release of cytochrome c indicated that the (−)-agelasidine A-mediated mitochondrial apoptosis was mechanistic. (−)-Agelasidine A also increased apoptosis-associated proteins (DR4, DR5, FAS), which are related to extrinsic pathways. These events were accompanied by an increase in Bim and Bax, proteins that promote apoptosis, and a decrease in the antiapoptotic protein, Bcl-2. Furthermore, our results presented that (−)-agelasidine A treatment bridged the intrinsic and extrinsic apoptotic pathways. Western blot analysis of Hep3B cells treated with (−)-agelasidine A showed that endoplasmic reticulum (ER) stress-related proteins (GRP78, phosphorylated PERK, phosphorylated eIF2α, ATF4, truncated ATF6, and CHOP) were upregulated. Moreover, 4-PBA, an ER stress inhibitor, could also abrogate (−)-agelasidine A-induced cell viability reduction, annexin V+ apoptosis, death receptor (DR4, DR5, FAS) expression, mitochondrial dysfunction, and cytochrome c release. In conclusion, by activating ER stress, (−)-agelasidine A induced the extrinsic and intrinsic apoptotic pathways of human HCC. MDPI 2022-01-29 /pmc/articles/PMC8875608/ /pubmed/35200638 http://dx.doi.org/10.3390/md20020109 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Lu, I-Ta
Lin, Shih-Chao
Chu, Yi-Chia
Wen, Ya
Lin, You-Cheng
Cheng, Wen-Chien
Sheu, Jyh-Horng
Lin, Chi-Chien
(−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
title (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
title_full (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
title_fullStr (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
title_full_unstemmed (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
title_short (−)-Agelasidine A Induces Endoplasmic Reticulum Stress-Dependent Apoptosis in Human Hepatocellular Carcinoma
title_sort (−)-agelasidine a induces endoplasmic reticulum stress-dependent apoptosis in human hepatocellular carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8875608/
https://www.ncbi.nlm.nih.gov/pubmed/35200638
http://dx.doi.org/10.3390/md20020109
work_keys_str_mv AT luita agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT linshihchao agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT chuyichia agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT wenya agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT linyoucheng agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT chengwenchien agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT sheujyhhorng agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma
AT linchichien agelasidineainducesendoplasmicreticulumstressdependentapoptosisinhumanhepatocellularcarcinoma